Memorial Sloan Kettering Bergen (Limited Protocol Activities)

The trials here

What the 152 trials at this site are about, from their registry records.

Conditions

• Lung cancer18 trials
• Sarcoma17 trials
• Multiple myeloma14 trials
• Prostate cancer14 trials
• Head and neck cancer12 trials
• Metastatic breast cancer12 trials
• Bladder cancer8 trials
• Childhood cancers8 trials
• Ovarian cancer8 trials
• Colorectal cancer7 trials
• Kidney cancer7 trials
• Pancreatic cancer6 trials
• and 24 more

Phase

• Phase 285 trials
• Phase 128 trials
• Phase 1/212 trials
• Early phase 13 trials
• Phase 32 trials

Status

• Recruiting84 trials
• Active, not recruiting48 trials
• Completed12 trials
• Not yet recruiting3 trials
• Terminated2 trials
• Withdrawn2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Memorial Sloan Kettering Cancer Center149 trials
• City of Hope Medical Center2 trials
• Ponce Medical School Foundation, Inc.1 trial

Running trials

• Not yet recruiting

  A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell Lymphoma

  NCT07799220· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Zachary Epstein-Peterson, MD

• Not yet recruiting

  A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

  NCT06941480· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Lisa Bodei, MD, PhD

• Recruiting

  A Study of Ropeg-Interferon in People With Polycythemia Vera

  NCT07886801· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Raajit Rampal, MD, PhD

• Recruiting

  Researching the Effect of Exercise on Cancer

  NCT04589468· City of Hope Medical Center· Source

  Contact: Lee Jones, MD

• Recruiting

  A Study of Armored CAR T Cells in People With Cancer

  NCT07783477· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Adam Schoenfeld, MD

• Recruiting

  A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery

  NCT07802353· Memorial Sloan Kettering Cancer Center· Source

  Contact: Luke Pike, MD

• Recruiting

  A Study of Romosozumab in People With Breast Cancer and Osteoporosis

  NCT07776613· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Monica Fornier, MD

• Recruiting

  A Study of Luspatercept in People With Anemia

  NCT07725497· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Jodi Mones, MD

• Recruiting

  A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

  NCT05751434· Phase 2· City of Hope Medical Center· Source

  Contact: Jessica Scott, PhD

• Recruiting

  A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

  NCT07671339· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Kevin Soares, MD

• Recruiting

  A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

  NCT07631000· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Yelena Janjigian, MD

• Recruiting

  A Study of Ivonescimab in People With Leiomyosarcoma

  NCT07516925· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Sandra D'Angelo, MD

• Recruiting

  A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

  NCT07400029· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Ioannis Kalogirou Valtis, MD

• Recruiting

  A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

  NCT07392242· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Kuo-Kai Chin, MD

• Recruiting

  A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

  NCT07390617· Memorial Sloan Kettering Cancer Center· Source

  Contact: Samuel Funt, MD

• Active, not recruiting

  A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

  NCT07335796· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Recruiting

  A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

  NCT07323732· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Narek Shaverdian, MD

• Recruiting

  A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

  NCT07089992· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Robert Maki, MD, PhD

• Recruiting

  A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

  NCT07227636· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Neil Segal, MD, PhD

• Recruiting

  A Dietary Study for People With Multiple Myeloma

  NCT07226609· Memorial Sloan Kettering Cancer Center· Source

  Contact: Urvi A Shah, MD, MS

• Recruiting

  A Study of 177Lu-PSMA-617 in People With Gliomas

  NCT07223034· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Brandon Imber, MD

• Recruiting

  DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

  NCT07225088· Ponce Medical School Foundation, Inc.· Source

  Contact: Devika Jutagir, PhD

• Recruiting

  A Study of Surgery and Radiotherapy in People With Breast Cancer

  NCT07053085· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Lior Braunstein, MD

• Recruiting

  A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

  NCT07105059· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Malin Hultcrantz, MD, PhD

• Recruiting

  A Study of Tarlatamab for People With Prostate Cancer

  NCT07111507· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Karen Autio, MD

• Recruiting

  A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

  NCT07099391· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Neha Korde, MD

• Recruiting

  A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

  NCT07063212· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Winston Wong, MD

• Recruiting

  A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

  NCT07011004· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Brian Shaffer, MD

• Recruiting

  A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

  NCT06984861· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Nancy Lee, MD

• Recruiting

  A Study of Hospital-at-Home for People Receiving Tarlatamab

  NCT06957314· Memorial Sloan Kettering Cancer Center· Source

  Contact: Robert Daly, MD, MBA

• Recruiting

  Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

  NCT06934889· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Thomas Kaley, MD

• Recruiting

  A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

  NCT06843967· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Olayode Babatunde, MD

• Recruiting

  A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

  NCT06835972· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Sahil Doshi, MD

• Recruiting

  A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

  NCT06699602· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Martin Voss, MD

• Recruiting

  A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  NCT06807632· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Jessica Ross, MD

• Recruiting

  A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

  NCT06765317· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Pallaw Torka, MD

• Recruiting

  A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

  NCT06773195· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Raajit Rampal, MD, PhD

• Recruiting

  A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

  NCT06736613· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Jennifer Lue, MD

• Recruiting

  A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

  NCT06679829· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Gunjan Shah, MD

• Active, not recruiting

  A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy

  NCT06671782· Memorial Sloan Kettering Cancer Center· Source

• Recruiting

  A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

  NCT06637462· Memorial Sloan Kettering Cancer Center· Source

  Contact: Paul Romesser, MD

• Recruiting

  A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

  NCT06623396· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Geoffrey Ku, MD

• Recruiting

  A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

  NCT06594991· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: James Smithy, MD

• Recruiting

  A Study of Sotorasib in People With Non-Small Cell Lung Cancer

  NCT06582771· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Gregory Riely, MD, PhD

• Recruiting

  A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

  NCT06563479· Phase 3· Memorial Sloan Kettering Cancer Center· Source

  Contact: Nancy Lee, MD

• Recruiting

  A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  NCT06457919· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Wassim Abida, MD, PhD

• Recruiting

  A Registry for People With Lung Cancer

  NCT06424327· Memorial Sloan Kettering Cancer Center· Source

  Contact: David Jones, MD

• Recruiting

  A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

  NCT06394804· Phase 2· Memorial Sloan Kettering Cancer Center· Source

  Contact: Rachel Grisham, MD

• Recruiting

  A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

  NCT05748197· Phase 1· Memorial Sloan Kettering Cancer Center· Source

  Contact: Jae Park, MD

• Recruiting

  A Study Collecting Health Information to Understand and Prevent Gastric Cancer

  NCT06370143· Memorial Sloan Kettering Cancer Center· Source

  Contact: Monika Laszkowska, MD

Showing 50 of 136.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer12 recruiting
• Sarcoma10 recruiting
• Head and neck cancer9 recruiting
• Metastatic breast cancer7 recruiting
• Childhood cancers6 recruiting
• Multiple myeloma6 recruiting
• Colorectal cancer5 recruiting
• Ovarian cancer5 recruiting
• Prostate cancer5 recruiting
• Acute myeloid leukaemia4 recruiting
• Kidney cancer4 recruiting
• Bladder cancer3 recruiting
• Gastric and oesophageal cancer3 recruiting
• Melanoma3 recruiting
• Pancreatic cancer3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Glioblastoma2 recruiting
• Mesothelioma2 recruiting
• Myeloproliferative neoplasms2 recruiting
• Neuroendocrine tumours2 recruiting
• Triple-negative breast cancer2 recruiting
• Brain metastases1 recruiting
• Chronic kidney disease1 recruiting
• Cushing's syndrome1 recruiting
• Endometrial cancer1 recruiting
• Follicular lymphoma1 recruiting
• Insomnia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Osteoporosis1 recruiting
• Pituitary tumours1 recruiting
• Thyroid cancer1 recruiting

Closed trials

• Withdrawn

  A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

  NCT07414992· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Withdrawn

  A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

  NCT07428044· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Terminated

  A Study of XmAb23104 in People With Sarcoma

  NCT05879185· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

  NCT05429320· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer

  NCT05239000· Memorial Sloan Kettering Cancer Center· Source

• Completed

  A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

  NCT05133440· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  A Study of Pembrolizumab and Cryoablation in People With Mesothelioma

  NCT05071014· Phase 1· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

  NCT04824443· Phase 1· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

  NCT04457284· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  ZW25 in Women With Endometrial Cancers

  NCT04513665· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors

  NCT04343573· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

  NCT04337970· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma

  NCT04068831· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

  NCT04042753· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Terminated

  A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

  NCT04019327· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

  NCT02675829· Phase 2· Memorial Sloan Kettering Cancer Center· Source